C Schiffler

Impact of regorafenib treatment on overall survival (OS) in advanced sarcoma patients.

Clémence Leguillette, C Schiffler, Jennifer Wallet, Sylvie Chabaud et autres

11556 Background: Regorafenib has been evaluated in several sarcoma clinical trials and the common primary endpoint of these studies was Progression-Free Survival (PFS) according to RECIST, with OS as secondary endpoint. We aimed to assess the impact of regorafenib on OS using …

fr (code pays fourni par la source)

438P Efficacity of tucatinib with trastuzumab (T) and pertuzumab (P) as maintenance therapy after local treatment of isolated brain progression for patient with HER2-positive metastatic breast cancer (mBC): InTTercePT UCBG-GINECO study

T. Bachelot, C Schiffler, B. Verret, I. Desmoulins et autres

More than 10% of HER2-positive mBC patients (pts) develop isolated central nervous system (CNS) metastases as initial site of progression when receiving first-line T+P. Currently, there is no evidence that modifying systemic treatment after local treatment could improve outcome. Tucatinib is an …

fr (code pays fourni par la source)

Six-year duration of adjuvant imatinib in high-risk GIST: more to come

Jean‐Yves Blay, C Schiffler, Sylvie Chabaud, D Perolc et autres

fr (code pays fourni par la source)

Author’s reply to the Letters to the Editor. Six years duration of adjuvant imatinib in high-risk GIST: more to come

Jean‐Yves Blay, C Schiffler, Sylvie Chabaud, D Perolc et autres

fr (code pays fourni par la source)

Six years duration of adjuvant imatinib improves disease-free survival in GIST with a high risk of relapse

Jean‐Yves Blay, Nicolas Penel, C Schiffler, Sylvie Chabaud et autres

fr (code pays fourni par la source)

480P CATRIPCA – A phase I of pembrolizumab (P) combined with Xevinapant (Debio 1143, (X)) in patients (pts) with non MSI-high advanced/metastatic pancreatic ductal adenocarcinoma (PDAC) or colorectal cancer (CRC)

P.A. Cassier, C. Terret, A. Voisin, C Schiffler et autres

fr, ch (code pays fourni par la source)